Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lin

Showing results (731-740 of 792) with videos related to

Pageof 80
Sort By:
Arthritis and Rheumatism|January 31, 2009
HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysmsY-J Lin, L Wan, J-Y Wu, et al.
Cancer Biology & Therapy|September 10, 2009
Anti-angiogenic properties of metronomic topotecan in ovarian carcinomaWilliam M Merritt, Christopher G Danes, Mian M K Shahzad, et al.
Gynecologic Oncology|April 26, 2025
Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trialBenoit You, Charles Anderson, Sabrina Chiara Cecere, et al.
Nature Communications|April 26, 2020
Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancerRosario I Corona, Ji-Heui Seo, Xianzhi Lin, et al.
The Lancet. Oncology|November 28, 2017
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trialSara A Hurvitz, Miguel Martin, W Fraser Symmans, et al.
Gynecologic Oncology|April 20, 2023
Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancerJocelyn Garcia-Sayre, Yvonne G Lin, Koji Matsuo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 11, 2015
Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolatesR S Garfein, D G Catanzaro, T C Rodwell, et al.
Cancer Research|November 3, 2007
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancerCharles N Landen, Yvonne G Lin, Guillermo N Armaiz Pena, et al.
Journal of the National Cancer Institute|November 2, 2006
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancerCharles N Landen, Chunhua Lu, Liz Y Han, et al.
Cancer Research|September 5, 2006
Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinomaLiz Y Han, Charles N Landen, Jose G Trevino, et al.
Pageof 80

Showing results (731-740 of 792) with videos related to

Sort By:
Pageof 80
Arthritis and Rheumatism|January 31, 2009
HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysmsY-J Lin, L Wan, J-Y Wu, et al.
Cancer Biology & Therapy|September 10, 2009
Anti-angiogenic properties of metronomic topotecan in ovarian carcinomaWilliam M Merritt, Christopher G Danes, Mian M K Shahzad, et al.
Gynecologic Oncology|April 26, 2025
Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trialBenoit You, Charles Anderson, Sabrina Chiara Cecere, et al.
Nature Communications|April 26, 2020
Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancerRosario I Corona, Ji-Heui Seo, Xianzhi Lin, et al.
The Lancet. Oncology|November 28, 2017
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trialSara A Hurvitz, Miguel Martin, W Fraser Symmans, et al.
Gynecologic Oncology|April 20, 2023
Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancerJocelyn Garcia-Sayre, Yvonne G Lin, Koji Matsuo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 11, 2015
Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolatesR S Garfein, D G Catanzaro, T C Rodwell, et al.
Cancer Research|November 3, 2007
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancerCharles N Landen, Yvonne G Lin, Guillermo N Armaiz Pena, et al.
Journal of the National Cancer Institute|November 2, 2006
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancerCharles N Landen, Chunhua Lu, Liz Y Han, et al.
Cancer Research|September 5, 2006
Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinomaLiz Y Han, Charles N Landen, Jose G Trevino, et al.
Pageof 80